Profiles in Lung Cancer – Day 14: Anne-Marie Baird, PhD “Lung cancer can affect anyone, anywhere”
PROFILES IN LUNG CANCER – DAY 14
Lung Cancer Awareness Month 2015
Dr Anne-Marie Baird, Lung Cancer Researcher and Advocate
“Lung cancer can affect anyone, anywhere.”
Twitter handle: @BairdAM
What is your connection with lung cancer?
Both my grandmother and aunt died from the disease. My aunt died while I was researching lung cancer at university.
What does your typical day look like?
I am usually in the lab or labland (as I call it) and am active on the Twitter feed #LCSM. Outside of the lab, I keep an eye out for dangerous Australian wildlife!
What is something we might not know about you?
I am close to obsessive in my god-motherly dealings with my delightful nephew Oscar. I reserve a special affection for … read more on Janet Freeman-Daily’s blog “Gray Connections”
SPECIAL EVENT: #LCSM+NCI Google Hangout & Twitter Chat at 11/19 at 2pm ET: “Changing Landscape of Lung Cancer Research & Treatment”
Last year in November, The National Cancer Institute (NCI) and #LCSM Chat worked together to conduct a Twitter chat on precision medicine in lung cancer treatment. This year, we’ve taken our collaboration a step further to create a highly engaging, interactive online event.
For Lung Cancer Awareness Month this year (#LCAM15), The NCI and #LCSM Chat are excited to announce we will co-host a one hour Google Hangout on Air on “The Changing Landscape of Lung Cancer Research and Treatment” on November 19, 2015 at 2:00 ET. You can watch the Hangout LIVE online by clicking HERE.
During the Google Hangout, we will also be co-hosting a simultaneous #LCSM Chat on Twitter on the same topic to expand on the discussion. If you have questions you would like answered by the experts in the Hangout, tweet them during the chat (or before) using the #LCSM hashtag. You can read about how to participate in an #LCSM Twitter chat here.
Our Hangout on Air will be moderated by #LCSM co-founder Janet Freeman-Daily (@JFreemanDaily), who will share questions submitted on Twitter with our three lung cancer experts:
- Shakun Malik, MD, head of thoracic oncology therapeutics at National Cancer Institute (@NCIDrMalik);
- Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, and a principal investigator on the SU2C-ACS Lung Cancer Dream Team (@DrRoyHerbstYale);
- David Tom Cooke MD, FACS, Head, Section of General Thoracic Surgery University of California at Davis, and an #LCSM Co-Founder (@DavidCookeMD).
During the Hangout, Dr. Jack West (@JackWestMD) will moderate the #LCSM Chat on Twitter. The questions in the chat will reflect the topics to be discussed in the Hangout:
- T1: What new aspects of lung cancer clinical research are you excited about? What’s new in clinical trials?
- T2: How is translational research different from clinical research? What new projects in translational research are you excited about?
- T3: What new directions in basic lung cancer research give you the most hope?
- T4: How can the lung cancer community help researchers to give us more new treatments sooner?
Feel free to tweet questions of the presenters in the #LCSM tweetchat—just include the hashtag “#LCSM” in your tweet. NCI social media people will collect the questions from the Twitter feed and feed them to Janet so she can ask them during the Hangout. If you’re not comfortable with Twitter, just post your question in the comment section of this blog post. We will make sure your question gets added to the list.
It promises to be a lively and vibrant discussion about current lung cancer research, clinical trials, and future treatment options. We hope you tune in to the Hangout on Air and/or join the #LCSM Chat on Twitter. If you aren’t able to join us live, don’t worry — the hangout will be recorded and posted on YouTube shortly after the event, and a Storify of the Twitter chat will be posted within a week. As usual, you can find transcripts of past #LCSM Chats on our “Schedules and Transcripts” page.
After the 11/19 Hangout is over, we’d appreciate your completing a brief survey to let us know what you thought about the Hangout, and what you would like to see in future #LCSM Hangouts. Click here to take the survey.
Profiles in Lung Cancer – Day 13: Diane Legg
It was March of 2006. Dana Reeves had just died and I was reeling. As a young woman with lung cancer, I’d hitched my star to Dana’s, and her loss felt terribly personal. But then I happened to pick up a copy of the Newburyport Daily News. Inside was a story about a young mother of three with lung cancer; Diane Legg. I found her phone number online and called her that afternoon. We chatted a couple more times but our plans to have coffee somehow never materialized.
Diane Legg and Hildy Grossman: two super advocates!
In 2008 my path and Diane’s crossed once again. I was attending Lung Cancer Alliance’s annual Shine a Light on Lung Cancer at the Prudential Center in Boston because my trial buddy Kevin Brumett was speaking—Kevin and I were early participants in the first clinical trial for an ALK inhibitor. Well, as a co-chairperson, Diane was there too and we finally got to meet. And the rest, as they say, is history.
I treasure Diane as a close friend but also as an inspiration; the first person I saw a little further down this path than myself.
Diane was only 42 when she was diagnosed with NSCLC. She’d strained a muscle while picking up her one year old and when the pain didn’t go away, she was scanned to rule out a pulmonary embolism. What they found instead was lung cancer.
The fact that Diane has lung cancer is not the reason she became a passionate advocate. Instead it was the death of a close family friend .. read more on Linnea Olson’s blog “life and breath: outliving lung cancer“
#LCSM 
You must be logged in to post a comment.